These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11328891)

  • 21. Hepatitis G and erythropoietin therapy in patients undergoing hemodialysis.
    Cengiz K; Günaydin M; Akpolat T; Pekbay A
    Nephron; 1998 Aug; 79(4):507. PubMed ID: 9689184
    [No Abstract]   [Full Text] [Related]  

  • 22. Is the use of subcutaneous epoetin beta once a week really equivalent to a more frequent administration of the same total dose?
    Andrulli S; D'Amico M; Locatelli F
    Nephrol Dial Transplant; 2001 Dec; 16(12):2439-40. PubMed ID: 11733645
    [No Abstract]   [Full Text] [Related]  

  • 23. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y; Inoue S; Horiguchi S; Kuki A
    Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Erythropoietin: current indications].
    Casadevall N
    Transfus Clin Biol; 2000 Jun; 7(3):255-6. PubMed ID: 10919214
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anemia in chronic renal failure. The role of L-carnitine in the treatment of anemia of hemodialyzed patients].
    Wanic-Kossowska M; Kurzawska-Firlej D; Kaźmierski M; Czekalski S
    Pol Arch Med Wewn; 2003 Jan; 109(1):105-11. PubMed ID: 12879773
    [No Abstract]   [Full Text] [Related]  

  • 27. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
    Nikolaev AIu; Klepikov PV; Lashutin SV
    Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
    [No Abstract]   [Full Text] [Related]  

  • 28. [Improving the administration of erythropoietin].
    Suszko P; Rousseau S; Poite O
    Soins; 2007 Oct; (719 Suppl):S22-3. PubMed ID: 18050874
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of human recombinant erythropoietin in children on chronic dialysis.
    Sallay P; Reusz G
    Acta Paediatr Hung; 1992; 32(4):333-45. PubMed ID: 1304191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with recombinant human erythropoietin in patients with aluminum overload and hyperparathyroidism.
    Grützmacher P; Ehmer B; Limbach J; Messinger D; Kulbe KD; Scigalla P
    Blood Purif; 1990; 8(5):279-84. PubMed ID: 2091687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group.
    Laupacis A
    Transplant Proc; 1991 Apr; 23(2):1825-6. PubMed ID: 2053167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of angiotensin-converting enzyme inhibitors on anemia in hemodialyzed patients.
    Teruel JL; Fernandez Juarez G; Marcen R; Nogueira J; Ortuño J
    Nephron; 1996; 73(1):113. PubMed ID: 8742977
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of erythropoietin administration on thyroid functions of the patients undergoing regular hemodialysis.
    Seyrek N; Paydas S; Sagliker Y
    Nephron; 1996; 72(4):714-5. PubMed ID: 8730452
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of renal anemia with recombinant human erythropoietin.
    Schaefer RM; Hörl WH; Massry SG
    Am J Nephrol; 1989; 9(5):353-62. PubMed ID: 2679093
    [No Abstract]   [Full Text] [Related]  

  • 35. Haemoglobin concentrations in chronic kidney disease.
    Steinbrook R
    Lancet; 2006 Dec; 368(9554):2191-3. PubMed ID: 17189015
    [No Abstract]   [Full Text] [Related]  

  • 36. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Korbet SM
    Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
    [No Abstract]   [Full Text] [Related]  

  • 37. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
    Schaefer RM; Heidland A
    Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190
    [No Abstract]   [Full Text] [Related]  

  • 38. [Advances in therapy of renal anemia: darbepoetin alfa].
    Schaefer R
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):955-7. PubMed ID: 12635460
    [No Abstract]   [Full Text] [Related]  

  • 39. [Recurrence of anemia after discontinuation of erythropoietin substitution].
    Jelkmann W
    Dtsch Med Wochenschr; 1991 Jul; 116(28-29):1127. PubMed ID: 2065604
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravenous iron and chronic kidney disease.
    Auerbach M
    Am J Hematol; 2014 Nov; 89(11):1083. PubMed ID: 25219516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.